Your browser doesn't support javascript.
loading
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.
Rulli, E; Marabese, M; Torri, V; Farina, G; Veronese, S; Bettini, A; Longo, F; Moscetti, L; Ganzinelli, M; Lauricella, C; Copreni, E; Labianca, R; Martelli, O; Marsoni, S; Broggini, M; Garassino, M C.
Affiliation
  • Rulli E; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan.
  • Marabese M; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan.
  • Torri V; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan.
  • Farina G; Department of Medical Oncology, Fatebenefratelli e Oftalmico Hospital, Milan.
  • Veronese S; Department of Pathology, Niguarda Cancer Center, Ospedale Niguarda Cà Granda, Milan.
  • Bettini A; Department of Medical Oncology, Papa Giovanni XXIII Hospital, Bergamo.
  • Longo F; Department of Medical Oncology, Università La Sapienza, Policlinico Umberto I, Rome.
  • Moscetti L; Department of Medical Oncology, Ospedale Belcolle, Viterbo.
  • Ganzinelli M; Thoracic Oncology Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Lauricella C; Department of Pathology, Niguarda Cancer Center, Ospedale Niguarda Cà Granda, Milan.
  • Copreni E; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan.
  • Labianca R; Department of Medical Oncology, Papa Giovanni XXIII Hospital, Bergamo.
  • Martelli O; Department of Medical Oncology, Ospedale San Giovanni e Addolorata, Rome.
  • Marsoni S; Clinical Trials Coordination Unit, Istituto di Candiolo-FPO, IRCCS, Candiolo, Italy.
  • Broggini M; Department of Oncology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan massimo.broggini@marionegri.it.
  • Garassino MC; Thoracic Oncology Unit, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
Ann Oncol ; 26(10): 2079-84, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26209642
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Proto-Oncogene Proteins p21(ras) / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms / Mutation Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Proto-Oncogene Proteins p21(ras) / Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms / Mutation Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Type: Article